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The developmental decrease of the intrinsic regenerative ability of the mammalian central
nervous system (CNS) is associated with reduced activity of mechanistic target of
rapamycin (mTOR) in mature neurons such as retinal ganglion cells (RGCs). While mTOR
activity is further decreased upon axonal injury, maintenance of its pre-injury level, for
instance by genetic deletion of the phosphatase and tensin homolog (PTEN), markedly
promotes axon regeneration in mammals. The current study now addressed the question
whether active mTOR might generally play a central role in axon regeneration by
analyzing its requirement in regeneration-competent zebrafish. Remarkably, regulation
of mTOR activity after optic nerve injury in zebrafish is fundamentally different compared
to mammals. Hardly any activity was detected in naïve RGCs, whereas it was markedly
increased upon axotomy in vivo as well as in dissociated cell cultures. After a short
burst, mTOR activity was quickly attenuated, which is contrary to the requirements
for axon regeneration in mammals. Surprisingly, mTOR activity was not essential for
axonal growth per se, but correlated with cytokine- and PTEN inhibitor-induced neurite
extension in vitro. Moreover, inhibition of mTOR using rapamycin significantly reduced
axon regeneration in vivo and compromised functional recovery after optic nerve injury.
Therefore, axotomy-induced mTOR activity is involved in CNS axon regeneration in
zebrafish similar to mammals, although it plays an ancillary rather than essential role
in this regeneration-competent species.
Keywords: mTOR, optic nerve regeneration, zebrafish, rapamycin, pS6
Introduction
The regenerative ability of the mammalian central nervous system (CNS) is dramatically
reduced after birth, causing impaired regeneration of severed axons in adult animals.
This regenerative failure is partly based on the limited intrinsic regenerative ability
of mammalian CNS neurons and the inhibitory environment of axonal growth cones
Abbreviations: 4E-BP1, 4E-binding protein 1; AKT, protein kinase B; bpV, bisperoxovanadium; CHAT, cholinergic
acetyl transferase; CNTF, ciliary neurotrophic factor; dpi, day(s) post injury; DRG, dorsal root ganglion; GAP43,
growth associated protein 43; GFP, green fluorescent protein; JAK, Janus kinase; LIF, leukemia inhibitory factor;
mTor, mechanistic target of rapamycin; PI3K, phosphatidylinositol 3-kinase; PTEN, phosphatase and tensin homolog;
RGC, retinal ganglion cell; S6, ribosomal protein S6; S6K1, ribosomal protein S6 kinase 1; STAT, signal transducer and
activator of transcription; TSC1, tuberous sclerosis complex 1.
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(Schwab and Bartholdi, 1996; Goldberg et al., 2002; Fischer and
Leibinger, 2012). However, some degree of axonal regeneration is
observed upon induction of cytokine expression by inflammatory
stimulation (Fischer et al., 2000; Leibinger et al., 2009, 2013;
Hauk et al., 2010), intravitreal application of ciliary neurotrophic
factor (CNTF) (Lingor et al., 2008; Müller et al., 2009) and virus-
mediated cytokine expression (Leaver et al., 2006; Pernet et al.,
2013). In addition, genetic manipulation of certain signaling
cascades, such as phosphatidylinositol 3-kinase/protein kinase
B/mechanistic target of rapamycin (PI3K/AKT/mTOR) and
Janus kinase/signal transducer and activator of transcription
(JAK/STAT) have been described to promote axon regeneration
(Cai et al., 2001; Gao et al., 2004; Fischer and Leibinger, 2012;
Diekmann and Fischer, 2013; Pernet et al., 2013). In particular,
genetic deletion of the phosphatase and tensin homolog (PTEN),
an opponent of PI3K, potently promotes axon regeneration of
RGCs, motor, corticospinal and peripheral neurons (Park et al.,
2008; Christie et al., 2010; Liu et al., 2010; Ning et al., 2010).
In RGCs, these effects were, for the most part, mimicked by
knockout of tuberous sclerosis complex 1 (TSC1), a negative
regulator of mTOR signaling (Park et al., 2008). Therefore, the
growth promoting effects of PTEN deletion have been mainly
attributed to sustained activity of downstream mTOR. This
serine-threonine protein kinase is central to a multi-functional
signaling network that integrates intra- and extracellular signals
to control cell proliferation, metabolism and survival (Maiese
et al., 2013). Upon nucleation into multi-protein complexes,
mTOR phosphorylates, among others, ribosomal protein S6
kinase 1 (S6K1) and eukaryotic initiation factor 4E-binding
protein 1 (4E-BP1), thereby promoting anabolic processes such
as protein and lipid synthesis (Laplante and Sabatini, 2009).
Inhibition of mTOR by rapamycin attenuates most of the
beneficial effects of PTEN deletion in RGCs, compromises optic
nerve regeneration upon inflammatory stimulation and partially
blocks the conditioning effect of sciatic nerve injury (Park et al.,
2008; Abe et al., 2010; Leibinger et al., 2012). Therefore, these
findings suggest that mTOR plays a central role in regenerative
processes of injured axons in mammals and raise the question
as to whether mTOR activity is also required for axon growth
stimulation in regeneration-competent animals.
In contrast to mammals, adult teleosts have the remarkable
ability to functionally regenerate injured CNS axons (Stuermer
et al., 1992; Bernhardt et al., 1996; Becker and Becker, 2007).
Upon crush or complete transection of the optic nerve, RGCs
survive and regrow axons through the optic nerve and tract
to topographically re-innervate their respective targets in the
brain, leading to functional restoration of the visual projection
within 2–4 weeks after injury (Stuermer et al., 1992; Bernhardt,
1999; McDowell et al., 2004). We recently established the
adult transgenic growth associated protein 43 (GAP43):green
fluorescent protein (GFP) zebrafish as a valuable tool for axon
regeneration studies, as they strongly express GFP only in
injured neurons and their regrowing axons (Diekmann et al.,
2015). In addition, the analysis of regenerating axons was
facilitated using a combination of wholemount optic nerve
tissue clearing and confocal microscopy (Diekmann et al.,
2015). Taking advantage of these novel approaches, we here
investigated the regulation of mTOR after optic nerve injury
in adult zebrafish and whether manipulation of mTOR activity
would impact RGC axon regeneration in vitro and in vivo.
Indeed, we detected pronounced, although transient increase
of mTOR activity in most RGCs upon optic nerve injury
in vivo as well as in dissociated cell cultures. Moreover,
inhibition of mTOR attenuated CNTF- and PTEN inhibitor-
induced, but not basal axonal growth in vitro as well as
axon regeneration in vivo. In addition, functional recovery in
vivo was significantly compromised upon rapamycin treatment,
indicating a contribution of mTOR signaling to spontaneous
axon regeneration in zebrafish.
Materials and Methods
Zebrafish
Adult, 4–9 months old wild-type or homozygous
Tg(GAP43:GFP) zebrafish (Udvadia, 2008), in the text referred
to as GAP43:GFP, were used for all experiments. Zebrafish
were reared and kept on a 14 h light/ 10 h dark cycle under
standard conditions (Westerfield, 1989). All experimental
procedures were approved by the local animal welfare committee
in Recklinghausen and conducted in compliance with federal
and state guidelines for animal experiments in Germany.
Dissociated Retinal Cell Cultures
Tissue culture plates (24- or 96-well-plates; Nunc) were coated
with poly-D-Lysine (0.1 mg/ml, molecular weight 3,00,000
Da; Sigma) for 30 min at 37◦C, rinsed twice with distilled
water and air-dried. Zebrafish were sacrificed by immersion
in MS222 (0.4 mg/l) and decapitation. Retinae were rapidly
dissected from the eyecups of naïve zebrafish and incubated in
a digestion solution containing papain (10 U/ml, Worthington)
and L-cysteine (0.3 µg/ml; Sigma) in L15/salt solution (12.5%
salt solution: 10 mM D-glucose, 1.26mM CaCl2, 32 mM
Hepes, pH 7.5/ 87.5% L15; Invitrogen) at room temperature
for 40 min. They were then rinsed with L15/salt solution
and triturated in 2 ml fish medium (2% FBS (Invitrogen),
0.2 mg/ml penicillin/streptomycin (Biochrom) in L15/salt
solution). Dissociated cells were passed through a cell strainer
(40 µm; Falcon) and counted using a TC10 Automated Cell
Counter (BioRad). Approximately 1.5 × 104 cells (96 well
plate) and 2.5 × 104 cells (24 well plate) were added to
each well, respectively. In some wells, 1 ng/ml mouse CNTF
(Peprotech), 10 nM rapamycin (LC Laboratories) or 10 nM
bisperoxovanadium (bpV(phen), Calbiochem) were added to
the culture medium. Cultures were incubated at 27.5 ◦C in a
humidified incubator for 2 h to 4 days. Cells were fixed with 4%
paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for
30 min at room temperature and permeabilized with Methanol
(5 min) for immunostaining. Neurite growth was determined
after 4 days in culture. RGCs with regenerated neurites were
visualized via GFP expression or acetylated tubulin antibody
(1:2,000; Sigma) immunostaining and photographed under a
fluorescent microscope (200×, Observer.D1, Zeiss). Neurite
length was determined using ImageJ software as previously
described (Diekmann et al., 2015). Mean neurite length was
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calculated by dividing the sum of neurite length by the number
of RGCs with regenerated neurites per well. Data are given
as means ± SEM of at least six replicate wells from at least
two independent experiments. The significance of intergroup
differences was evaluated using Two-Way Anova with Holm-
Sidak post hoc tests (GraphPad; SigmaStat).
Optic Nerve Crush
For surgery, zebrafish were anesthetized by immersion in MS222
(0.18 mg/l; Sigma). The eye was slightly pulled out of its orbit
to expose the optic nerve. Taking care to spare the ophthalmic
artery, the optic nerve was intra-orbitally crushed ∼0.5 mm
behind the eye for 5 s using jeweler’s forceps (FST), as described
previously (Bormann et al., 1999; Liu and Londraville, 2003;
Diekmann et al., 2015).
In vivo Rapamycin Treatment
A rapamycin stock of 1 mg/ml was prepared in DMSO.
Immediately after optic nerve crush, fish were placed into 0.2µM
rapamycin (1:5,000 dilution of stock in fish water) or 0.02%
DMSO as control. Solutions were changed daily.
Retinal Cross Sections
Zebrafish were sacrificed by prolonged immersion in MS222 (0.4
mg/l) and decapitation. Eye(s) were removed and fixed in 4%
PFA/PBS at 4◦C overnight. Subsequently, eyes were immersed
in 30% sucrose and embedded in Tissue-Tek (Sakura). Frozen
sections (14 µm) were cut on a CM3050S cryostat (Leica), thaw-
mounted onto glass slides (Superfrost plus; ThermoFisher) and
stored at−80◦C until further use.
Immunohistochemistry
Retinal cross sections were permeabilized with 100% Methanol
for 5 min at room temperature. After blocking with 2%
BSA/5% donkey serum/PBS, they were incubated with either
pS6(Ser235/236) (1:500; Cell Signaling #4857), choline acetyl
transferase (CHAT; 1:100; Millipore AB144P) or acetylated
tubulin (1:1,000; Sigma T6793) antibodies overnight at 4◦C.
The protein sequence of zebrafish ribosomal S6 around
the detected phosphorylation site is 100% identical to the
human peptide used for antibody generation. After several
washes with PBS, bound antibodies were visualized with
anti-mouse or anti-goat secondary antibodies conjugated to
Alexa Fluor 488 or Alexa Fluor 594 (1:1,000; Molecular
Probes). Fluorescent sections were embedded in Mowiol and
analyzed under a fluorescent microscope (200×, Observer.D1,
Zeiss). The percentage of pS6-positive cells was calculated
in relation to the number of cells stained with acetylated
tubulin in the ganglion cell layer (RGCs) and CHAT-positive
cells in the inner nuclear layer (INL; amacrines), respectively,
on six sections from 2–3 different zebrafish at each time
point.
Quantification of Axon Regeneration
Two and a half days after optic nerve crush, zebrafish were
sacrificed by prolonged immersion in MS222 (0.4 mg/l) and
decapitation. The lower jaw and gills were removed and the eyes
pulled slightly out of their sockets to stretch the optic nerves. The
head was then fixed in 75 mM Lysine/2% PFA/10 mM NaIO4
overnight at 4◦C. After fixation, the optic nerves were dissected
with part of the retina attached and placed into FocusClear
solution (BioRad) overnight for clearing. They were embedded in
MountClear and scanned using a confocal microscope (LSM510,
Zeiss). For quantification of axon regeneration, axon profiles
within the nerve diameter were counted on five individual
z-sections at 200 and 500 µm distal from the lesion site,
respectively. ‘‘Axons per mm’’ was calculated by dividing the
number of axons per site by the diameter of the nerve of the
respective z-section. Data are given as means ± SEM of eight
optic nerves per group from two independent experiments.
The significance of intergroup differences was evaluated using
Two-Way ANOVA with Holm-Sidak post hoc tests (GraphPad;
SigmaStat).
Dorsal Light Reaction
Fish swim in a slightly oblique position (∼10◦) upon unilateral
optic nerve injury (Figure 5E; Lindsey and Powers, 2007;
Mensinger and Powers, 2007), which is gradually reversed with
ongoing regeneration. Therefore, the degree of tilt can serve as
a measure for functional regeneration. At various times after
optic nerve injury, fish were placed into a 2.7 × 17.5 cm
container with 400 ml water. After ∼5 min adaptation, they
were recorded on video for 1–2 min, making sure to capture
at least five straight swims directly towards the camera.
The videos were analyzed frame by frame and still pictures
taken if the whole body of the fish was positioned straight
towards the camera. The angle between the fish body position
(straight line through the eyes; Figure 5E) and the horizon
was then determined using ImageJ. At least seven different
pictures were analyzed per fish and time point to calculate
the mean divergent angle. Data are given as means ± SEM
of at least five fish per group. The significance of intergroup
differences was evaluated using Repeat-Measurements Two-
Way ANOVA with Holm-Sidak post hoc tests (GraphPad;
SigmaStat).
RNA Isolation and Quantitative Real-Time PCR
For quantitative real-time PCR, both retinae from one zebrafish
were dissected and combined. Total RNA was isolated using
the RNeasy Mini kit (Qiagen, Germany) according to the
manufacturer’s instructions, including the removal of genomic
DNA. Total RNA (300 ng) was reverse transcribed using the
SuperScript II reverse transcriptase kit (Invitrogen, USA).
Gfp, gap43 and glyceraldehyde 3-phosphate dehydrogenase
(gapdh) were amplified using SYBR Green PCR Master
Mix (Applied Biosystems, Foster City, CA, USA) and
primers gfp-for (5′-GCAAGCTGACCCTGAAGTTC-3′),
gfp-rev (5′-GGTGCGCTCCTGGACGTA-3′), gap43-for (5′-
TGCTGCATCAGAAGAACTAA-3′), gap43-rev (5′-CCTCCG
GTTTGATTCCATC-3′), gapdh-for (5′-CCTCCGGTTTGAT
TCCATC-3′) and gapdh-rev (5′-GGCGGTGTAGGCATGAAC-
3′) on an Applied Biosystems 7500 real-time PCR system
(Life Technologies) using 45 amplification cycles according to
the manufacturer’s protocol. PCR efficiency was confirmed
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for each primer pair and specificity verified with the
dissociation curve analysis feature. Gfp and gap43 mRNA
expression levels in rapamycin-treated vs. control retinae were
quantified using the ∆∆Ct method (Livak and Schmittgen,
2001) with gapdh as the reference gene. All reactions were
performed in triplicate and at least three independent samples
(from different zebrafish) were analyzed per experimental
group.
Results
Optic Nerve Injury Induces mTOR Activity in
Zebrafish Retinae
In order to analyze mTOR activity upon optic nerve regeneration
in zebrafish, we examined the spatiotemporal distribution of
phosphorylated ribosomal protein S6 (pS6), a downstream
effector of mTOR, on retinal cross sections at various times
after optic nerve injury (Figure 1). In naïve, uninjured
zebrafish retinae, pS6 immunostaining was detected only
in a few cells of the INL (Figure 1A). In comparison, S6
phosphorylation was quickly, although transiently induced
in acetylated tubulin-positive RGCs upon optic nerve crush
(Figures 1A,B,D). At 2 days post injury (dpi), 78.1 ± 3.8%
RGCs were strongly positive for pS6, whereas hardly any
pS6 signal was detected in RGCs at time points beyond
4 dpi (Figure 1D). Interestingly, injury-induced mTOR
activation was also observed in cholinergic amacrines identified
by co-staining with antibodies against cholinergic acetyl
transferase (CHAT) in the INL (Figures 1A,C,D). However,
pS6 immunoreactivity in amacrines was only significantly
increased at 4–16 dpi. Thus, optic nerve injury induced mTOR
activation in RGCs and amacrine cells with different time
courses.
mTOR Activity is Induced in Cultured RGCs
To test whether mTOR is also activated in axotomized
RGCs in vitro, we co-stained dissociated retinal cultures from
naïve zebrafish with pS6 and acetylated tubulin antibodies
at various time points. At 2 h in culture, already 36.7 ±
2.5% RGCs were pS6-positive (Figure 2A). This proportion
rose to 50.8 ± 1.9% by 6 h and stayed at this level for 2
days before significantly declining at 4 days in culture (25.7
± 2.4%). Therefore, mTOR activity was similarly induced
in axotomized RGCs in culture and in vivo. The faster
onset and lower overall penetrance (∼50 vs. ∼80%; compare
Figures 1D, 2A) is likely attributable to the cell culture
conditions.
To assess whether mTOR activity could be modulated by
cytokines similar to mammalian RGCs (Park et al., 2008;
Leibinger et al., 2012), some retinal cultures were concurrently
treated with CNTF. CNTF has recently been shown to promote
neurite growth of zebrafish RGCs (Elsaeidi et al., 2014; Diekmann
et al., 2015) and indeed significantly increased the percentage
of pS6-positive RGCs at 2 and 6 h compared to controls
(52.6 ± 2% and 62.8 ± 2.1%, respectively) (Figures 2A,B).
However, no CNTF-induced increase of mTOR activity was
observed at 1, 2 and 4 days in culture (Figure 2A). Interestingly,
FIGURE 1 | Retinal mTOR activation upon optic nerve injury.
(A) Immunohistochemistry of phosphorylated S6 (pS6) on retinal cross
sections at 0, 2 and 12 days post injury (dpi) indicates induction of mTOR
activity in the ganglion cell (GCL, arrows) and inner nuclear (INL, arrowheads)
layers after optic nerve axotomy. (B) Co-immunostaining of a retinal cross
section (2 dpi) with pS6 (red) and acetylated tubulin (green) antibodies
identifies pS6-positive cells as retinal ganglion cells (RGCs; arrows). (C)
Co-immunostaining of a retinal cross section (0 dpi) with pS6 (red) and choline
acetyl transferase (CHAT, green) antibodies identifies cholinergic amacrine
cells (arrowheads). (D) Time course of pS6-positive RGCs (blue) and
amacrines (red) after optic nerve crush. Data represent means ± SEM of two
independent experiments. GCL = ganglion cell layer; IPL = inner plexiform
layer; INL = inner nuclear layer. Scale bar = 25 µm.
addition of CNTF to retinal cultures at 1 day post dissociation
could similarly not promote increased pS6 levels (data not
shown), indicating insensitivity to CNTF at later incubation
times.
We also validated that mTOR activation was indeed the
underlying cause of S6 phosphorylation in zebrafish RGCs.
Application of the potent mTOR inhibitor rapamycin abolished
S6 phosphorylation in RGCs, independent of CNTF treatment
(Figures 2B,C). Conversely, the PTEN inhibitor bpV(phen),
which promotes PI3K and subsequently mTOR activity (Posner
et al., 1994; Schmid et al., 2004), significantly increased
the percentage of pS6-positive RGCs either alone or in
combination with CNTF compared to untreated controls
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FIGURE 2 | Induction of mTOR activity in cultured RGCs.
(A) Quantification of the percentage of retinal ganglion cells (RGCs) positive for
phosphorylated S6 (pS6) at 2 and 6 hours (h) as well as 1, 2 and 4 days (d) in
culture with or without ciliary neurotrophic factor (CNTF; 1 ng/ml) treatment.
Data represent means ± SEM of three independent experiments, each with
three repeats. Treatment effects: p < 0.001. (B) Representative pictures of
cultured RGCs stained with pS6 (red) and acetylated tubulin (green) antibodies
at 6 h in culture. Cells were either treated with vehicle (con), CNTF (1 ng/ml) or
CNTF + rapamycin (Rap; 10 nM). Scale bar = 50 µm. (C) Percentage of
pS6-positive RGCs at 6 h in culture after treatment with either vehicle (−),
rapamycin (Rap; 10 nM), PTEN inhibitor bisperoxovanadium (bpV(phen);
10 nM), or bpV(phen) + Rap. Data represent means ± SEM of at least two
independent experiments, each with three repeats. Treatment effects:
p < 0.001.
(65.7 ± 1.1% (bpV) and 71.9 ± 1.4% (bpV + CNTF)
vs. 52.2 ± 0.4% (control); Figure 2C). Similar to CNTF
treatment, bpV(phen) was unable to increase mTOR activity
upon application at 1 day in culture (data not shown).
Concurrent bpV(phen) + rapamycin treatment again annulled
S6 phosphorylation (Figure 2C), indicating that bpV(phen) acts
on S6 through increasing mTOR activity. Overall, the extent of
S6 phosphorylation correlates with mTOR activity in zebrafish
RGCs.
Induction of Neurite Growth Correlates with
mTOR Activity
In an effort to evaluate whether mTOR activity is required
for axonal growth, we next measured neurites of isolated
RGCs grown in the presence of rapamycin (mTOR inhibition)
or bpV(phen) (mTOR activation). Interestingly, rapamycin
concentrations abolishing S6 phosphorylation (Figures 2B,C)
did not affect neurite growth per se [72.4 ± 1.9 µm (Rap) vs.
68.0 ± 0.8 µm (untreated control)]. However, treatment with
either CNTF or bpV(phen), which increased mTOR activity
to comparable extents, significantly increased neurite growth
of dissociated RGCs (82.0 ± 1.3 µm and 85.6 ± 2.2 µm,
respectively; Figures 3A,B). Moreover, combination of CNTF
and bpV(phen), which increased mTOR activity the most
(Figure 2C), also showed longer outgrowth than each treatment
alone (97.6± 3.8µm). These growth-promoting effects of CNTF
and bpV(phen) were abrogated in the presence of rapamycin
[69.4 ± 1.4 µm (CNTF + Rap), 71.1 ± 0.4 µm (bpV + Rap) and
70.5 ± 1.3 µm (CNTF + bpV + Rap)], indicating a correlation
between increased mTOR activity and PI3K/AKT-stimulated
neurite growth in culture (Figure 3B). Thus, mTOR activity is
seemingly not required for basal axon growth, but enhanced
FIGURE 3 | Correlation of mTOR activity with CNTF- and PTEN
inhibitor-induced neurite growth of cultured RGCs. (A) Representative
pictures of cultured retinal ganglion cells (RGCs) stained with acetylated
tubulin antibody at 4 days in culture and exposure to vehicle (con) and ciliary
neurotrophic factor (CNTF, 1 ng/ml), respectively. Scale bar = 50 µm.
(B) Quantification of average RGC neurite length at 4 days in culture after
treatment with either vehicle control (−), rapamycin (Rap; 10 nM), PTEN
inhibitor bpV(phen) (10 nM), or bpV(phen) + Rap. Data represent means ±
SEM of at least two independent experiments, each with three repeats.
Treatment effects: p < 0.001.
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levels are sufficient to promote further growth of RGC neurites
in culture.
Inhibition of mTOR Activity Compromises Axon
Regeneration and Functional Recovery
In an attempt to investigate the relevance of mTOR activity
for axonal regeneration, we first explored pharmacological
approaches for efficient mTOR inhibition in vivo. In our hands,
neither intravitreal nor intraperitoneal injections of rapamycin
yielded consistent, longer-term down-regulation of retinal S6
phosphorylation (data not shown). Therefore, zebrafish were
placed directly into either DMSO- or rapamycin-containing
water immediately after optic nerve crush, as similar treatment
has previously been shown to impede mTOR induction upon fin
amputation (Hirose et al., 2014). Using this approach, mTOR
activation was efficiently inhibited as verified by abolished
pS6 levels on retinal cross-sections (Figure 4). Whereas S6
phosphorylation was strongly induced in RGCs of control retinae
at 2 dpi (Figure 4A) and in cholinergic amacrines at 6 dpi
(Figure 4C), no pS6 staining was detected in rapamycin-treated
zebrafish at these time points (Figures 4B,D). Therefore, mTOR
activity also underlies increased S6 phosphorylation upon optic
nerve injury in vivo and can be prevented longer-term by
supplementing the fish water with rapamycin.
To investigate whether inhibition of mTOR activity would
impact axon regeneration upon optic nerve injury, we took
advantage of our recently established protocol that enables
the accurate analysis of regenerating axons in wholemount
optic nerve preparations using GAP43:GFP transgenic zebrafish
(Diekmann et al., 2015). As previously described, quite a few
severed axons had already grown past the lesion site back into
the injured nerve at 2.5 dpi in control animals (Figures 5A,A′).
In comparison, rapamycin treatment reduced the number and/or
length of regenerating axons as quantified at two different
sites posterior to the lesion (Figures 5B,B′,C). Similarly, pixel
intensities were reduced in optic nerves of rapamycin-treated
zebrafish at 5 dpi (data not shown). Systemic rapamycin
treatment has previously been described to reduce GAP43
expression in peripheral, but not optic nerves in mice (Abe et al.,
2010; Leibinger et al., 2012). Therefore, we next addressed the
possibility that the observed reduction of regenerating axons
was rather based on impaired GFP expression. To this end,
we compared transgenic gfp and endogenous gap43 mRNA
expression levels in vehicle- and rapamycin-treated retinae by
quantitative RT-PCR (Figure 5D). In comparison to control
animals, neither gfp nor gap43 expression was significantly
changed at 2 dpi in rapamycin-treated retinae, thereby excluding
this possibility.
Finally, we investigated whether rapamycin-induced
impairment of axonal regeneration would have functional
consequences. As reported previously, zebrafish swim slightly
oblique towards the side of the intact eye upon unilateral
optic nerve crush (Figure 5E). This tilt lessens progressively
with ongoing axonal regeneration (Lindsey and Powers, 2007;
Mensinger and Powers, 2007). Thus, the swimming position
can be used as an indicator for functional recovery of vision.
In the vehicle-treated control group, significant improvements
were initially detected at 11 dpi (7.2◦ vs. 10.9◦ at 1 dpi) and
the swimming angle lessened to 4.2◦ at 18 dpi. In comparison,
rapamycin-treated zebrafish swam in a significantly more tilted
position from 11 dpi (10.1◦) up to 18 dpi (6.5◦; Figure 5F).
Thus, impairment of mTOR activity upon optic nerve injury
FIGURE 4 | Efficient inhibition of mTOR activity in zebrafish in vivo.
(A, B, B′) Immunostaining of retinal cross sections with phosphorylated
S6 (pS6, red) and acetylated tubulin (green) antibodies at 2 days post
injury. Fish were either treated with DMSO (A) or 0.2 µM rapamycin
(Rap, B) prior to tissue preparation. Rapamycin treatment abrogated pS6
staining in retinal ganglion cells (RGCs; arrows). (C,D,D′) Immunostaining
of retinal cross sections with pS6 (red) and choline acetyl transferase
(CHAT; green) antibodies at 6 days post injury. Fish were either treated
with DMSO (C) or 0.2 µM rapamycin (Rap, D) prior to tissue
preparation. Rapamycin treatment abolished pS6 staining in amacrines
(arrowheads). GCL = ganglion cell layer; IPL = inner plexiform layer;
INL = inner nuclear layer; Scale bar = 25 µm.
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FIGURE 5 | Compromised axon regeneration and functional recovery
upon mTOR inhibition. (A,B) Maximum intensity projections (85 × 0.9 µm
confocal z-sections) of wholemount optic nerves from DMSO- (A) and 0.2 µM
rapamycin (Rap, B) -treated GAP43::GFP zebrafish at 2.5 days post injury
(dpi). The lesion site is indicated with a dashed line, proximal is to the left.
Scale bar = 200 µm. (A′,B′) Higher magnifications of the boxed areas in
(A) and (B), respectively, using maximum intensity projections of 10 × 0.9 µm
confocal stacks. Scale bar = 50 µm. (C) Quantification of axon profiles per
mm optic nerve diameter on single z-sections at 200 and 500 µm posterior to
the lesion site of DMSO- and rapamycin-treated zebrafish, respectively (for
details see “Materials and Methods” Section). Data represent means ± SEM
of 8 optic nerves from two independent experiments. Treatment effects
compared to DMSO control: ***p < 0.001; *p < 0.05 (D) Quantitative real-time
PCR for green fluorescent protein (gfp) and growth associated protein 43
(gap43) in relation to glyceraldehyde-3-phosphate dehydrogenase (gapdh) in
retinae isolated from zebrafish 2 days post injury that were treated either with
vehicle (DMSO) or 0.2 µM rapamycin (Rap), respectively. Data represent mean
∆∆Ct ± SEM of at least three different fish per experimental group.
ns = non-significant (E) Representative pictures of the swimming position of a
naïve zebrafish and a fish 1 day post unilateral right optic nerve crush (1 dpi),
respectively. (F) Quantification of the oblique swimming position of DMSO
(blue)- and rapamycin (Rap; red)-treated zebrafish at 1, 4, 11, 13, 14 and 18
days post injury (dpi). In addition, some zebrafish received
rapamycin-treatment only during the first 3 days of the experiment (RD;
brown). Another group was initially held in DMSO (0–3 dpi) and then
transferred to rapamycin for the remainder of the experiment (DR; green). Data
represent means ± SEM of at least five zebrafish per group. Treatment effects
compared to DMSO control: ***p < 0.001; **p < 0.01.
significantly compromised axonal regeneration and functional
recovery. Interestingly, reduced regeneration was also observed
upon temporary rapamycin treatment early after optic nerve
crush (0–3 dpi), correlating with increased mTOR activity in
RGCs (Figure 5F). On the other hand, late rapamycin application
(4–18 dpi) had no effect on visual recovery, indicating that the
delay of functional recovery was caused by abolished mTOR
activation in RGCs within the first days after injury and that
mTOR induction in cholinergic amacrines at later time points is
negligible for optic nerve regeneration. Overall, mTOR signaling
seems not absolutely essential for axonal regeneration, as
rapamycin could only delay, rather than completely block axon
growth and functional recovery. Nevertheless, the initial burst of
mTOR activity upon optic nerve injury, which is fundamentally
different to its regulation in mammals, supports regenerative
processes in regeneration-competent zebrafish.
Discussion
The current study characterizes the relevance of active mTOR
for axonal regrowth and functional recovery after optic
nerve injury in a regeneration-competent CNS model. Indeed,
mTOR activity was markedly, although temporarily induced
in zebrafish RGCs upon optic nerve injury in vivo as well
as in dissociated neuronal cell cultures. However, mTOR
activity was not essential for axonal growth per se, but
correlated with cytokine- and PTEN inhibitor-induced neurite
extension in vitro. Moreover, inhibition of mTOR using
rapamycin significantly reduced axonal regeneration in vivo
and compromised functional recovery after optic nerve injury.
Thus, regulation of mTOR activity after axonal injury in
regeneration-competent zebrafish seems fundamentally different
from the non-regenerating mammalian CNS. Nevertheless,
active mTOR contributes to axon regeneration in both
systems.
Induction of mTOR in zebrafish retina upon optic nerve
injury was monitored using the phosphorylation levels of
ribosomal protein S6 as described previously (Park et al., 2008;
Leibinger et al., 2012). S6 is phosphorylated by S6K1, which itself
is a target of mTOR. Accordingly, rapamycin as an established
mTOR inhibitor diminished pS6 levels in retinal cell cultures
as well as in vivo. In addition, stimulation of mTOR through
the PI3K/AKT pathway with either the cytokine CNTF or the
PTEN inhibitor bpV(phen) consistently elevated pS6 levels in
dissociated RGCs. Therefore, the phosphorylation status of S6
can be used as a faithful readout of mTOR activity in zebrafish
retinae.
The progression of mTOR activity after optic nerve injury
in zebrafish differed significantly from the one in rodents. In
retinae from naïve, adult mice, only 10–15% of RGCs contain
high levels of phosphorylated S6 and reportedly have the highest
probability to regenerate (Duan et al., 2015). This proportion
is even further reduced upon optic nerve injury (Park et al.,
2008; Leibinger et al., 2012). In contrast, no pS6 staining
was observed in RGCs of naïve zebrafish retinae. However,
S6 phosphorylation in RGCs was markedly induced in vivo
shortly after optic nerve injury as well as in dissociated cell
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cultures. In addition, prolonged mTOR induction was observed
in cholinergic amacrines after an initial lag phase. The activity of
mTOR is reportedly controlled by the PI3K/AKT, MAPK/ERK,
CDK42/phopholipase D and wnt pathways (Fang et al., 2001,
2003; Ma et al., 2005; Huang and Manning, 2009; Hirose et al.,
2014). Interestingly, leukemia inhibitory factor (LIF), a IL6-
like cytokine, which reportedly activates the PI3K/AKT/mTOR
pathway in rodents (Li et al., 2014), is strongly upregulated
in zebrafish RGCs early after axotomy (Ogai et al., 2014) and
could potentially contribute to the transient mTOR activation
(Figure 6). However, the elucidation of the detailed stimuli
involved in activating mTOR after optic nerve injury in zebrafish
awaits further investigations.
The burst of mTOR activity in RGCs shortly after optic
nerve injury was quickly attenuated, as hardly any pS6-positive
RGCs were detected at 4 dpi. This again approximately coincides
with the attenuation of LIF expression in zebrafish (Ogai
et al., 2014). In addition, activated mTOR itself has been
shown to strongly repress the PI3K/AKT pathway upstream of
PI3K, thereby forming a negative feedback loop (Harrington
et al., 2005; Manning and Cantley, 2007). Furthermore, S6K1-
mediated phosphorylation of Rictor inhibits mTORC2 and AKT
signaling (Julien and Roux, 2010). Both of these auto-regulatory
mechanisms could be involved in the observed mTOR down-
regulation in zebrafish RGCs (Figure 6A). Interestingly, mTOR
activity could not be induced by CNTF or PTEN inhibitor
application at later time points in culture, indicating potential
deactivation of this signaling pathway during later regenerative
processes. For this reason, augmentation of in vivo mTOR
activity with the PTEN inhibitor in an attempt to experimentally
increase axon regeneration is envisaged impractical.
Overall, the observed time course of S6 phosphorylation
matches the regulation of mTOR activity after injury in another
regeneration competent model, the mammalian sciatic nerve.
Two-fold increased pS6 levels were detected in dorsal root
ganglion (DRG) neurons at 1 dpi that returned to basal levels
FIGURE 6 | Schematic showing the ancillary contribution of mTOR
activity to axon regeneration in adult zebrafish. (A) Upon optic nerve
injury, diverse and prevalently unknown molecular mechanisms (gray arrow)
are activated in adult zebrafish RGCs to enable axon growth and functional
regeneration. Among others, cytokines such as LIF are released and activate
the JAK/STAT and PI3K/AKT/mTOR pathways that contribute to axon
regeneration. The initial burst of mTOR activity could then be quickly
attenuated by negative feedback loops (red lines). (B) Inhibition of mTOR
using rapamycin only partially reduces axon regrowth and compromises
functional recovery, suggesting an ancillary rather than essential role of mTOR
activity in zebrafish optic nerve regeneration.
by 4 dpi (Abe et al., 2010). Comparably, S6K phosphorylation
was also transiently induced in regenerating blastemal cells
6 h to 3 days after zebrafish fin amputation (Hirose et al.,
2014), consistently indicating short bursts of mTOR activity
in regenerating tissues. In contrast, impaired regeneration in
the mammalian CNS is associated with reduced mTOR activity
in mature neurons, which is further decreased upon axonal
injury (Park et al., 2008; Leibinger et al., 2012). Therefore,
mTOR regulation in regeneration-competent (mammalian PNS,
zebrafish) and -incompetent (mammalian CNS) systems seems
fundamentally different and it would be interesting to analyze
the effect of a comparable course of mTOR activity (short
burst of strong mTOR activity in all RGCs followed by quick
down-regulation) on the regenerative ability of mammalian CNS
neurons.
Similar to mouse RGCs, basal neurite growth in cell culture
was not affected by rapamycin treatment in zebrafish, as pS6-
negative RGCs grew neurites equally well (Leibinger et al., 2012
and this study). On the other hand, mTOR activity closely
correlated with PI3K/AKT-induced axonal growth of zebrafish
RGCs. Consistent with previous reports (Elsaeidi et al., 2014;
Diekmann et al., 2015), application of the cytokine CNTF or
the PTEN-inhibitor pbV(phen) increased pS6 levels as well
as neurite length in culture and this growth-promotion was
abrogated in the presence of rapamycin. In mice RGCs, on
the contrary, rapamycin could only compromise the neurite
growth promoting effect of CNTF on myelin substrate, but
not on laminin (Leibinger et al., 2012). The underlying cause
for these disparate observations might be founded on the
non-inhibitory nature of the fish optic nerve (Wanner et al.,
1995). Similar to its effect in culture, rapamycin reduced, but
not completely blocked axonal regrowth in vivo (Figure 6B).
Remarkably, LIF induction after axotomy follows a similar
time course as mTOR activation and functional recovery after
optic nerve injury is similarly delayed upon LIF knockdown
(Ogai et al., 2014). Therefore, it is quite conceivable that
the partial inhibition of axonal regeneration upon rapamycin
treatment reflects impaired PI3K/AKT/mTOR signaling, which,
consistent with our in vitro results, would depend on LIF
or other cytokine release shortly after axotomy (Figure 6B).
Further experiments need to address this possibility in the
future. As mTOR activity is quickly down-regulated after
a short burst, it would be interesting to analyze whether
prolonged activation of this pathway would lead to enhanced
axon regeneration or whether the observed deactivation is
essentially required for later regenerative processes. Due to the
likely presence of intrinsic negative feedback loops within this
pathway (Figure 6), these experiments might require inducible,
RGC-specific expression of constitutively active mTOR mutants.
Unfortunately, this approach is currently rather impractical in
adult zebrafish.
Maintenance of pre-injury mTOR activity levels in injured
mammalian RGCs, for instance by RGC-specific genetic
deletion of PTEN, markedly promotes in vivo axon regeneration
(Park et al., 2008; Smith et al., 2009). Likewise, constitutive
activation of mTOR upon genetic deletion of TSC1 potently
enhances axon regeneration of RGCs and DRG neurons
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(Park et al., 2008; Abe et al., 2010). On the other hand, the
number of regenerating mouse RGC axons upon inflammatory
stimulation was reduced by rapamycin treatment only at long
distances, whereas the extent of short axons remained unaffected
(Leibinger et al., 2012). These findings were interpreted in
a way that mTOR is not essentially required for the initial
switch of neurons into an active regenerative state. However,
increased mTOR activity is seemingly important to maintain
the regenerative state, potentially due to enhanced protein
and lipid biosynthesis. In zebrafish, axon regeneration after
optic nerve crush was significantly compromised, but not
completely inhibited by rapamycin, suggesting a comparable
ancillary role of mTOR in this regeneration-competent
species.
Obviously, systemic rapamycin treatment could inhibit
mTOR activity in cell types other than RGCs. For example,
mTOR signaling has been shown to regulate oligodendrocyte
differentiation and CNS myelination (Narayanan et al., 2009;
Tyler et al., 2009) and the positive effects of rapamycin treatment
after contusive spinal cord injury have been partly attributed
to reduced secondary neural tissue damage due to suppression
of macrophage/microglia activation and abrogation of reactive
astrogliosis (Kanno et al., 2012). In addition, it is now known
that chronic rapamycin treatment could inhibit mTORC2 just
as the classic target mTORC1, thereby potentially affecting
cytoskeleton dynamics (Sarbassov et al., 2006). However,
it is currently unknown whether these processes/cell types
might be involved in optic nerve regeneration in zebrafish.
Nevertheless, the conclusion of a rather RGC-specific effect
of our results is supported by the time course of mTOR
activation and the differential functional recovery upon timed
rapamycin treatment. Axon regeneration was only compromised
in zebrafish receiving rapamycin at early time points after
optic nerve crush (0–3 dpi), when mTOR was markedly
induced in RGCs, whereas delayed rapamycin treatment (4–18
dpi) had no effect. Therefore, the induction of mTOR in
cholinergic amacrines does not seem to contribute to optic nerve
regeneration. Similarly, the observed reduction of regenerating
axons upon rapamycin treatment could not be ascribed to
impaired GFP marker expression. In contrast to mTOR-
dependent induction of GAP43 in injured rodent sciatic
nerves (Abe et al., 2010), no reduction of GAP43 promoter-
driven gfp transcription was detected in zebrafish retinae
upon rapamycin treatment. This result is in accordance with
data showing no influence of rapamycin on the expression
of GAP43 and other regeneration-associated genes in rodent
retinae after inflammatory stimulation (Leibinger et al., 2012)
and again indicates that inhibition of mTOR activity does not
generally impair the transformation of RGCs into a regenerative
state.
In conclusion, the current study demonstrates the differential
regulation of mTOR activity in CNS regeneration-competent
vs. -incompetent models. Although not required for basal
axon growth, our data suggest that the early burst of
mTOR activity still contributes to the positive regenerative
outcome in zebrafish. Therefore, further mechanistic
insights into functional axon regeneration are provided,
highlighting that, at least in fish, other signaling pathways
than mTOR are more crucially involved in CNS axon
regeneration.
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